Orpea SA

  • Market Cap: N/A
  • Industry: Hospital
  • ISIN: FR0000184798
EUR
13.01
-0.29 (-2.18%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Orpea SA stock-summary
stock-summary
Orpea SA
Hospital
Orpea SA is a France-based company that is engaged in the operations of retirement homes, outpatient and rehabilitation clinics, and psychiatric care. Through its wholly owned subsidiary, Clinea, the Company also offers a range of other services, from outpatient treatment, post-operation care and physical therapy, to nursing, geriatric care, psychiatric services and long-term care homes. The Company operates a number of wholly owned subsidiaries, including Clinea, Villers Services SA, Residence La Cheneraie SAS, Carina SA, Super Aix SCI, Emcejidey SA, Maison de Retraite Paul Cezanne SA and Inoges AG, among others. It operates through Vitalis, Senevita, Dr. Dr. Wagner group and Anavita, operator of nursing homes in the Czech Republic.
Company Coordinates stock-summary
Company Details
12 Rue Jean Jaures, Puteaux Cedex , PUTEAUX None : 92813
stock-summary
Tel: 33 1 47757807
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 2 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Philippe Charrier
Independent Chairman of the Board
Mr. Yves Le Masne
Chief Executive Officer, Financial Director, Member of the Executive Committee and Director
Ms. Sophie Kalaidjian
Director, Employee Representative
Ms. Laure Baume
Independent Director
Mr. Xavier Coirbay
Independent Director
Ms. Bernadette Danet-Chevallier
Independent Director
Mr. Jean-Patrick Fortlacroix
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
378 Million
(Quarterly Results - Dec 2012)
Net Profit:
stock-summary
Industry

Hospital

stock-summary
Market cap

EUR 2,163 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

3.02

stock-summary
Return on Equity

-17.46%

stock-summary
Price to Book

1.36